268
Views
3
CrossRef citations to date
0
Altmetric
Review

Combination therapy for early rheumatoid arthritis: a treatment holiday perspective

&

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ayako Yamaguchi, Shintaro Hirata, Satoshi Kubo, Shunsuke Fukuyo, Kentaro Hanami, Kazuhisa Nakano, Shingo Nakayamada, Kazuyoshi Saito & Yoshiya Tanaka. (2020) 5-year remission rate after the discontinuation of adalimumab in patients with rheumatoid arthritis: Long-term follow-up results of the HONOR study. Modern Rheumatology 30:5, pages 799-806.
Read now

Articles from other publishers (2)

N. V. Demidova, E. A. Galushko, S. I. Glukhova, N. M. Savushkina, A. M. Satybaldyev, M. V. Cherkasova, N. V. Khoroshko, S. V. Maglevanyi & A. V. Gordeev. (2018) ADALIMUMAB DISCONTINUATION IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER ACHIEVING SUSTAINED REMISSION. Rheumatology Science and Practice 56:3, pages 316-320.
Crossref
Aaron Michels, Li Zhang, Anmar Khadra, Jake A. Kushner, Maria J. Redondo & Massimo Pietropaolo. (2015) Prediction and prevention of type 1 diabetes: update on success of prediction and struggles at prevention. Pediatric Diabetes 16:7, pages 465-484.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.